Subscribe for the VF E-News HERE
The Vasculitis Patient-Powered Research Network (V-PPRN) has been approved to receive a three-year $1.4 million award by the Patient-Centered Outcomes Research Institute (PCORI) as part of the second phase of more »
Sites throughout the U.S. and Canada are seeking patients with newly diagnosed or relapsed anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis. This clinical trial is designed to determine whether a new non-steroidal more »
The VF Board of Directors is pleased to announce that it has selected three new research studies for funding this year. The Vasculitis Foundation collaborates with researchers around the world more »
Mechanisms across the continuum, from those who avoid or play victim, to those who fight and communicate to the disease process that it met the wrong person.
The Vasculitis Foundation is pleased to announce it has selected two new research studies on EGPA/Churg Strauss for funding in the amount of $98,000. EGPA/CSS is a serious rare autoimmune more »